In this issue:
Epidemiology, treatment and outcomes of TBI
Bariatric surgery vs community weight management intervention for IIH
Efgartigimod in patients with generalised myasthenia gravis
Can pioglitazone delay cognitive impairment in people at risk for AD?
Long-term safety and efficacy of eculizumab in AQP4 IgG-positive NMOSD
Twin study evaluates genetic contribution to early AD
Real-world study of enzyme replacement therapy in Pompe disease
BMI is associated with disease severity in spinocerebellar ataxia type 2
Lovastatin may slow disease progression in patients with early-stage PD
RFC1 expansions are a common cause of idiopathic sensory neuropathy
Please login below to download this issue (PDF)